Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration
Crossref DOI link: https://doi.org/10.1186/s40942-015-0015-6
Published Online: 2015-09-03
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dhrami-Gavazi, Elona
Balaratnasingam, Chandrakumar
Lee, Winston
Freund, K. Bailey
Funding for this research was provided by:
The LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Hospital, New York, NY, USA, and The Macula Foundation, Inc., New York, NY, USA